Osimertinib-Induced Cardiotoxicity by Kartik Anand, MD, Joe Ensor, PhD, Barry Trachtenberg, MD, Eric H. Bernicker, MD

Get full text

Targeting mTOR and DNA repair pathways in residual triple negative breast cancer post neoadjuvant chemotherapy by Kartik Anand, Tejal Patel, Polly Niravath, Angel Rodriguez, Jorge Darcourt, Anna Belcheva, Toniva Boone, Joe Ensor, Jenny Chang

Get full text

T-cell lymphoma secondary to checkpoint inhibitor therapy by Patrick Hwu, Kartik Anand, Joe Ensor, Sai Ravi Pingali, Madeleine Duvic, Stephen Chiang, Roberto Miranda, Youli Zu, Swaminathan Iyer

Get full text

Hydroxytyrosol, a Component of Olive Oil for Breast Cancer Prevention in Women at High Risk of Cancer by Akshjot Puri, Zheng Yin, Sergio Granados-Principal, Joe Ensor, Liliana Guzman, Roberto Rosato, Hong Zhao, Stephen Wong, Lin Wang, Tejal Patel, Jenny C. Chang

Get full text

BESPOKE IO protocol: a multicentre, prospective observational study evaluating the utility of ctDNA in guiding immunotherapy in patients with advanced solid tumours by Zeynep Eroglu, Joe Ensor, Meenakshi Malhotra, Paul Billings, Angel Rodriguez, Alexey Aleshin, Ling Gao, Sarah Sawyer, Pashtoon Murtaza Kasi, Sascha Ellers, George Ansstas, Michael Krainock, Sakti Chakrabarti, Andrew Poklepovic, Minu Maninder

Get full text

Trial Protocol of a Phase II Study of mFOLFOXIRI after Metastasectomy in Patients with Oligometastatic Colorectal Cancer (FANTASTIC Study) by Kozo Kataoka, Takeshi Yamada, Kentaro Yamazaki, Keita Mori, Nobuhisa Matsuhashi, Manabu Shiozawa, Takuma Iwai, Masahiro Goto, Masayoshi Yasui, Yasumasa Takii, Takeshi Suto, Yasuyuki Takamizawa, Naoto Takase, Shruti Sharma, Joe Ensor, Adham Jurdi, Minetta C. Liu, Masataka Ikeda, Yukihide Kanemitsu

Get full text